Trials / Completed
CompletedNCT04891419
JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population
A Multicenter, Evaluator-blinded, Randomized, No-treatment Controlled Study to Evaluate the Safety and Effectiveness of JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 168 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to evaluate the safety and effectiveness of JUVÉDERM® VOLUMA® with Lidocaine injectable gel in adult Chinese population seeking correction of temple hollowing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | JUVÉDERM® VOLUMA® with Lidocaine | JUVÉDERM® VOLUMA® with Lidocaine injectable gel |
Timeline
- Start date
- 2021-07-20
- Primary completion
- 2023-11-22
- Completion
- 2023-11-22
- First posted
- 2021-05-18
- Last updated
- 2024-12-12
- Results posted
- 2024-12-12
Locations
8 sites across 1 country: China
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04891419. Inclusion in this directory is not an endorsement.